Raymond Daniel P, Seder Christopher W, Wright Cameron D, Magee Mitchell J, Kosinski Andrzej S, Cassivi Stephen D, Grogan Eric L, Blackmon Shanda H, Allen Mark S, Park Bernard J, Burfeind William R, Chang Andrew C, DeCamp Malcolm M, Wormuth David W, Fernandez Felix G, Kozower Benjamin D
Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
University Thoracic Surgeons, Rush Medical University, Chicago, Illinois.
Ann Thorac Surg. 2016 Jul;102(1):207-14. doi: 10.1016/j.athoracsur.2016.04.055. Epub 2016 May 28.
The purpose of this analysis was to revise the model for perioperative risk for esophagectomy for cancer utilizing The Society of Thoracic Surgeons General Thoracic Surgery Database to provide enhanced risk stratification and quality improvement measures for contributing centers.
The Society of Thoracic Surgeons General Thoracic Surgery Database was queried for all patients treated for esophageal cancer with esophagectomy between July 1, 2011, and June 30, 2014. Multivariable risk models for major morbidity, perioperative mortality, and combined morbidity and mortality were created with the inclusion of surgical approach as a risk factor.
In all, 4,321 esophagectomies were performed by 164 participating centers. The most common procedures included Ivor Lewis (32.5%), transhiatal (21.7%), minimally invasive esophagectomy, Ivor Lewis type (21.4%), and McKeown (10.0%). Sixty-nine percent of patients received induction therapy. Perioperative mortality (inpatient and 30-day) was 135 of 4,321 (3.4%). Major morbidity occurred in 1,429 patients (33.1%). Major morbidities include unexpected return to operating (15.6%), anastomotic leak (12.9%), reintubation (12.2%), initial ventilation beyond 48 hours (3.5%), pneumonia (12.2%), renal failure (2.0%), and recurrent laryngeal nerve paresis (2.0%). Statistically significant predictors of combined major morbidity or mortality included age more than 65 years, body mass index 35 kg/m(2) or greater, preoperative congestive heart failure, Zubrod score greater than 1, McKeown esophagectomy, current or former smoker, and squamous cell histology.
Thoracic surgeons participating in The Society of Thoracic Surgeons General Thoracic Surgery Database perform esophagectomy with low morbidity and mortality. McKeown esophagectomy is an independent predictor of combined postoperative morbidity or mortality. Revised predictors for perioperative outcome were identified to facilitate quality improvement processes and hospital comparisons.
本分析的目的是利用胸外科医师协会普通胸外科数据库修订食管癌食管切除术的围手术期风险模型,以为参与中心提供强化的风险分层和质量改进措施。
查询胸外科医师协会普通胸外科数据库,获取2011年7月1日至2014年6月30日期间接受食管癌食管切除术治疗的所有患者的数据。创建了主要并发症、围手术期死亡率以及并发症和死亡率综合情况的多变量风险模型,将手术入路作为一个风险因素纳入其中。
共有164个参与中心实施了4321例食管切除术。最常见的手术方式包括艾弗·刘易斯术式(32.5%)、经裂孔术式(21.7%)、微创食管切除术(艾弗·刘易斯型,21.4%)和麦克基翁术式(10.0%)。69%的患者接受了诱导治疗。围手术期死亡率(住院期间和30天内)为4321例中的135例(3.4%)。1429例患者发生了主要并发症(33.1%)。主要并发症包括意外返回手术室(15.6%)、吻合口漏(12.9%)、再次插管(12.2%)、初始通气超过48小时(3.5%)、肺炎(12.2%)、肾衰竭(2.0%)和喉返神经麻痹(2.0%)。主要并发症或死亡率综合情况的统计学显著预测因素包括年龄超过65岁、体重指数35kg/m²或更高、术前充血性心力衰竭、Zubrod评分大于1、麦克基翁食管切除术、当前或既往吸烟者以及鳞状细胞组织学类型。
参与胸外科医师协会普通胸外科数据库的胸外科医生实施食管切除术的发病率和死亡率较低。麦克基翁食管切除术是术后并发症或死亡率综合情况的独立预测因素。确定了围手术期结果的修订预测因素,以促进质量改进过程和医院间比较。